Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2.
Proc Natl Acad Sci U S A
; 119(9)2022 03 01.
Article
in En
| MEDLINE
| ID: mdl-35217606
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Single-Domain Antibodies
/
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Type of study:
Risk_factors_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2022
Document type:
Article
Affiliation country:
Belgium
Country of publication:
United States